![](/img/cover-not-exists.png)
52 COMPARISON OF MOLECULAR MARKERS, SUB-STAGE AND THE EORTC RISK-SCORE TO PREDICT CLINICAL OUTCOME OF PT1 BLADDER CANCER
B.W.G. Van Rhijn, T.H. Van Der Kwast, B. Bapat, P.J. Bostrom, N.E. Fleshner, M.N.M. Van Der Aa, L. Liu, C.H. Bangma, M.A.S. Jewett, E.C. Zwarthoff, A.R. ZlottaVolume:
9
Year:
2010
DOI:
10.1016/s1569-9056(10)60060-7
File:
PDF, 83 KB
2010